Record

RefNoHF/1/3/12/2/31
Previous numbers98HF.46.2.31
LevelItem
TitleN G Heatley to J C Woodruff, Merck and Co Inc, Rahway, New Jersey
Date3 August 1942
DescriptionQuotes cable he received from Dr Major [29 July] concerning Dr Maxwell of May and Baker - has visited Maxwell and Dr Wenyon of the Wellcome Research Institution - in both cases, it was concluded that he would not come into the picture until agreements had been made between ICI and the Therapeutic Research Corporation or between TRC and Merck - is working on a penicillin assay method applicable to small quantities of blood - discusses visit to Dr Wiesner and strain of aspergillus clavatus with which Wiesner has been working - Burroughs Wellcome have applied for provisional patents for medium for penicillin production and possibly also for some stages in the extraction - comments on this - refers to recent papers by Abraham and Chain, and by Florey and Jennings, and to paper by Gardner and Chain on proactinomycin - has not yet assayed samples of penicillin he brought back from Rahway - comments on the ring test.
Extent2pp
FormatCarbon copy
AccessStatusOpen
Add to My Items

    Collection highlights

    Browse the records of some of our collections, which cover all branches of science and date from the 12th century onwards. These include the published works of Fellows of the Royal Society, personal papers of eminent scientists, letters and manuscripts sent to the Society or presented at meetings, and administrative records documenting the Society's activities since our foundation in 1660.

    The Royal Society

    The Royal Society is a Fellowship of many of
    the world's most eminent scientists and is the
    oldest scientific academy in continuous existence.
    Registered charity number 207043

    Website design ©CalmView



    CONTACT US

    + 44 207 451 2500
    (Lines open Mon-Fri, 9:00-17:00. Excludes bank holidays)

    6-9 Carlton House Terrace, London SW1Y 5AG

    Email Us →

    SUBSCRIBE

    Subscribe to our newsletters to be updated with the
    latest news on innovation, events, articles and reports.

    Subscribe →

    © CalmView